Challenges in research on the neural basis of "chemobrain"

Translational Neuroscience

Volumn 5, Issue 3, 2014, Pages 222-225

  Kaiser, Jochen ^a   Dietrich, Jörg ^b  

^a GOETHE UNIVERSITY   (Germany)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Brain imaging; Chemotherapy; Cognitive impairment

Indexed keywords

ATTENTION DISTURBANCE; BRAIN DAMAGE; BRAIN SIZE; CANCER CHEMOTHERAPY; COGNITIVE DEFECT; CONFERENCE PAPER; EVENT RELATED POTENTIAL; HUMAN; MEMORY DISORDER; MENTAL PERFORMANCE; NERVE CELL NETWORK; NEUROIMAGING; NONHUMAN; PRIORITY JOURNAL; THERAPY EFFECT; THOUGHT DISORDER; WORKING MEMORY;

EID: 84906249362     PISSN: 20813856     EISSN: 20816936     Source Type: Journal    
DOI: 10.2478/s13380-014-0223-9     Document Type: Conference Paper

References (47)

1. Wefel J.S., Witgert M.E., Meyers C.A., Neuropsychological sequelae of non-central nervous system cancer and cancer therapy, Neuropsychol. Rev., 2008, 18, 121-131
2. Wefel J.S., Schagen S.B., Chemotherapy-related cognitive dysfunction, Curr. Neurol. Neurosci. Rep., 2012, 12, 267-275
3. Collins B., MacKenzie J., Tasca G.A., Scherling C., Smith A., Cognitive efects of chemotherapy in breast cancer patients: a dose-response study, Psychooncology, 2013, 22, 1517-1527
4. Wefel J.S., Lenzi R., Theriault R., Buzdar A.U., Cruickshank S., Meyers C.A., 'Chemobrain' in breast carcinoma?: a prologue, Cancer, 2004, 101, 466-475
5. Hermelink K., Kuchenhoff H., Untch M., Bauerfeind I., Lux M.P., Buhner M., et al., Two diferent sides of 'chemobrain': determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study, Psychooncology, 2010, 19, 1321-1328
6. Hutchinson A.D., Hosking J.R., Kichenadasse G., Mattiske J.K., Wilson C., Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review, Cancer Treat. Rev., 2012, 38, 926-934
7. Koppelmans V., Breteler M.M., Boogerd W., Seynaeve C., Gundy C., Schagen S.B., Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy, J. Clin. Oncol., 2012, 30, 1080-1086
8. Senf B., Brandt H., Dignass A., Kleinschmidt R., Kaiser J., Psychosocial distress in acute cancer patients assessed with an expert rating scale, Supp. Care Cancer, 2010, 18, 957-965
9. Hermelink K., Untch M., Lux M.P., Kreienberg R., Beck T., Bauerfeind I., et al., Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study, Cancer, 2007, 109, 1905-1913 (Pubitemid 46668557)
10. Ahles T.A., Saykin A.J., McDonald B.C., Furstenberg C.T., Cole B.F., Hanscom B.S., et al., Cognitive function in breast cancer patients prior to adjuvant treatment, Breast Cancer Res. Treat., 2008, 110, 143-152 (Pubitemid 351793851)
11. Dietrich J., Han R., Yang Y., Mayer-Proschel M., Noble M., CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo, J. Biol., 2006, 5, 22
12. Han R., Yang Y.M., Dietrich J., Luebke A., Mayer-Proschel M., Noble M., Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system, J. Biol., 2008, 7, 12
13. Hyrien O., Dietrich J., Noble M., Mathematical and experimental approaches to identify and predict the effects of chemotherapy on neuroglial precursors, Cancer Res., 2010, 70, 10051-10059
14. Monje M., Dietrich J., Cognitive side efects of cancer therapy demonstrate a functional role for adult neurogenesis, Behav. Brain Res., 2012, 227, 376-379
15. Seigers R., Fardell J.E., Neurobiological basis of chemotherapy-induced cognitive impairment: a review of rodent research, Neurosci. Biobehav. Rev., 2011, 35, 729-741
16. Seigers R., Schagen S.B., Van Tellingen O., Dietrich J., Chemotherapy-related cognitive dysfunction: current animal studies and future directions, Brain Imaging Behav., 2013, 7, 453-459
17. Nokia M.S., Anderson M.L., Shors T.J., Chemotherapy disrupts learning, neurogenesis and theta activity in the adult brain, Eur. J. Neurosci., 2012, 36, 3521-3530
18. Winocur G., Henkelman M., Wojtowicz J.M., Zhang H., Binns M.A., Tannock I.F., The efects of chemotherapy on cognitive function in a mouse model: a prospective study, Clin. Cancer Res., 2012, 18, 3112-3121
19. Fardell J.E., Vardy J., Johnston I.N., The short and long term efects of docetaxel chemotherapy on rodent object recognition and spatial reference memory, Life Sci., 2013, 93, 596-604
20. Fardell J.E., Zhang J., De Souza R., Vardy J., Johnston I., Allen C., et al., The impact of sustained and intermittent docetaxel chemotherapy regimens on cognition and neural morphology in healthy mice, Psychopharmacology, 2014, 231, 841-852
21. Kaiser J., Bledowski C., Dietrich J., Neural correlates of chemotherapy-related cognitive impairment, Cortex, 2014, 54, 33-50
22. Scherling C.S., Smith A., Opening up the window into " chemobrain": a neuroimaging review, Sensors, 2013, 13, 3169-3203
23. Simo M., Rifa-Ros X., Rodriguez-Fornells A., Bruna J., Chemobrain: a systematic review of structural and functional neuroimaging studies, Neurosci. Biobehav. Rev., 2013, 37, 1311-1321
24. Pomykala K.L., de Ruiter M.B., Deprez S., McDonald B.C., Silverman D.H., Integrating imaging findings in evaluating the post-chemotherapy brain, Brain Imaging Behav., 2013, 7, 436-452
25. Koppelmans V., de Ruiter M.B., van der Lijn F., Boogerd W., Seynaeve C., van der Lugt A., et al., Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy, Breast Cancer Res. Treat., 2012, 132, 1099-1106
26. de Ruiter M.B., Reneman L., Boogerd W., Veltman D.J., Caan M., Douaud G., et al., Late efects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging, Human Brain Mapp., 2012, 33, 2971-2983
27. McDonald B.C., Conroy S.K., Smith D.J., West J.D., Saykin A.J., Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: A replication and extension study, Brain. Behav. Immun., 2013, 30 (Suppl.), S117-125
28. McDonald B.C., Saykin A.J., Alterations in brain structure related to breast cancer and its treatment: chemotherapy and other considerations, Brain Imaging Behav., 2013, 7, 374-387
29. Kesler S., Janelsins M., Koovakkattu D., Palesh O., Mustian K., Morrow G., et al., Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors, Brain Behav. Immun., 2013, 30 (Suppl.), S109-116
30. Deprez S., Billiet T., Sunaert S., Leemans A., Difusion tensor MRI of chemotherapy-induced cognitive impairment in non-CNS cancer patients: a review, Brain Imaging Behav., 2013, 7, 409-435
31. Morioka S., Morimoto M., Yamada K., Hasegawa T., Morita T., Moroto M., et al., Efects of chemotherapy on the brain in childhood: difusion tensor imaging of subtle white matter damage, Neuroradiol., 2013, 55, 1251-1257
32. Kreukels B.P., Hamburger H.L., de Ruiter M.B., van Dam F.S., Ridderinkhof K.R., Boogerd W., et al., ERP amplitude and latency in breast cancer survivors treated with adjuvant chemotherapy, Clin. Neurophysiol., 2008, 119, 533-541
33. Kreukels B.P., Schagen S.B., Ridderinkhof K.R., Boogerd W., Hamburger H.L., Muller M.J., et al., Efects of high-dose and conventional-dose adjuvant chemotherapy on long-term cognitive sequelae in patients with breast cancer: an electrophysiologic study, Clin. Breast Cancer, 2006, 7, 67-78 (Pubitemid 43862837)
34. Kreukels B.P., Schagen S.B., Ridderinkhof K.R., Boogerd W., Hamburger H.L., van Dam F.S., Electrophysiological correlates of information processing in breast-cancer patients treated with adjuvant chemotherapy, Breast Cancer Res. Treat., 2005, 94, 53-61 (Pubitemid 41416942)
35. Bruno J., Hosseini S.M., Kesler S., Altered resting state functional brain network topology in chemotherapy-treated breast cancer survivors, Neurobiol. Dis., 2012, 48, 329-338
36. Kesler S.R., Wefel J.S., Hosseini S.M., Cheung M., Watson C.L., Hoeft F., Default mode network connectivity distinguishes chemotherapytreated breast cancer survivors from controls, Proc. Natl. Acad. Sci. USA, 2013, 110, 11600-11605
37. Kesler S.R., Bennett F.C., Mahafey M.L., Spiegel D., Regional brain activation during verbal declarative memory in metastatic breast cancer, Clin. Cancer Res., 2009, 15, 6665-6673
38. Lopez Zunini R.A., Scherling C., Wallis N., Collins B., MacKenzie J., Bielajew C., et al., Differences in verbal memory retrieval in breast cancer chemotherapy patients compared to healthy controls: a prospective fMRI study, Brain Imaging Behav., 2013, 7, 460-477
39. McDonald B.C., Conroy S.K., Ahles T.A., West J.D., Saykin A.J., Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study, J. Clin. Oncol., 2012, 30, 2500-2508
40. Conroy S.K., McDonald B.C., Smith D.J., Moser L.R., West J.D., Kamendulis L.M., et al., Alterations in brain structure and function in breast cancer survivors: efect of post-chemotherapy interval and relation to oxidative DNA damage, Breast Cancer Res. Treat., 2013, 137, 493-502
41. de Ruiter M.B., Reneman L., Boogerd W., Veltman D.J., van Dam F.S., Nederveen A.J., et al., Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer, Human Brain Mapp., 2011, 32, 1206-1219
42. Kesler S.R., Kent J.S., O'Hara R., Prefrontal cortex and executive function impairments in primary breast cancer, Arch. Neurol., 2011, 68, 1447-1453
43. O'Farrell E., MacKenzie J., Collins B., Clearing the air: a review of our current understanding of "chemo fog", Curr. Oncol. Rep., 2013, 15, 260-269
44. Caceres A., Hall D.L., Zelaya F.O., Williams S.C., Mehta M.A., Measuring fMRI reliability with the intra-class correlation coeficient, Neuroimage, 2009, 45, 758-768
45. Cimprich B., Reuter-Lorenz P., Nelson J., Clark P.M., Therrien B., Normolle D., et al., Prechemotherapy alterations in brain function in women with breast cancer, J. Clin. Exp. Neuropsychol., 2010, 32, 324-331
46. Scherling C., Collins B., Mackenzie J., Bielajew C., Smith A., Prechemotherapy diferences in visuospatial working memory in breast cancer patients compared to controls: an FMRI study, Front. Hum. Neurosci., 2011, 5, 122
47. Deprez S., Amant F., Smeets A., Peeters R., Leemans A., Van Hecke W., et al., Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning, J. Clin. Oncol., 2012, 30, 274-281